Diagnosis of the Heart – Chapter 4
Evan
Evan stared at the lab report, the words “Oligoclonal bands: POSITIVE” hitting him with unexpected force. He’d been preparing for this possibility since first noticing Priya’s tremor, yet seeing the confirmation printed in stark medical type made it suddenly, uncomfortably real. Not just a research subject, a colleague with early signs of MS.
He’d been calibrating the centrifuge when the courier burst through the lab door at 8:07 a.m., breaking his methodical rhythm. “Stat CSF results for Dr. Davis,” the young man had announced, brandishing the sealed envelope with the hospital’s pathology stamp.
“I didn’t order any stat processing,” Evan said, glancing up from the analyzer he’d been programming.
“Dr. Wolfe did.” The courier extended the envelope. “Said you’d want these ASAP.”
Matthew looked up from across the lab where he’d been arranging collection tubes in precise rows. “Must be Dr. Raman’s samples from yesterday afternoon.”
Evan’s pulse quickened as he accepted the envelope. Garrett Wolfe, as Chief of Medicine, had apparently expedited Priya’s cerebrospinal fluid analysis. The gesture was professionally courteous but complicated the timeline Evan had been carefully constructing.
“Thanks,” he told the courier, who nodded and disappeared back through the doorway.
The lab returned to its morning quiet, the soft hum of refrigeration units, the occasional beep from calibrating equipment. The research wing remained half-finished around them, but this space had been prioritized, gleaming with new equipment and the sharp scent of disinfectant.
“The processing protocols are all loaded,” Matthew said, gesturing toward the main analyzer. “We can run the neurofilament light assays as soon as the reagents arrive next week.”
Evan nodded absently, his attention fixed on the envelope. He slid his thumb beneath the seal, careful not to tear the contents. Inside was a standard hospital lab report, the header bearing Priya’s name and medical record number.
His eyes went immediately to the results section: Oligoclonal bands: POSITIVE (≥2 bands present in CSF, not detected in serum). The finding was significant, these protein markers appeared in the spinal fluid of most MS patients but rarely in healthy individuals. Not definitive alone, but a major piece of the diagnostic puzzle.
The finding left him with complicated emotions. It was a clinical data point that somehow felt intensely personal. These protein markers appeared in ninety percent of MS patients but rarely in healthy individuals. The rational part of his brain processed this as expected data, he’d suspected MS from his first observation of her tremor. But another part, one he usually kept carefully compartmentalized during research, imagined Priya receiving this news. How her expression would change. How her life would shift on this axis of before and after.
“Is it what you expected?” Matthew asked, moving closer.
“Yes and no.” Evan set the report on the counter, tapping his finger beside the results. “The bands are there, but I wasn’t expecting the analysis so quickly. We’re still collecting baseline data.”
Matthew peered at the report. “Positive oligoclonal bands. That’s pretty suggestive, right?”
“It’s one piece of evidence,” Evan corrected, his tone more clipped than he’d intended. “MS diagnosis requires multiple criteria, clinical presentation, imaging findings, exclusion of alternative explanations.”
“But this means she meets the study inclusion criteria?”
“Potentially.”
Evan folded the report and slipped it into his lab coat pocket, where it seemed to burn against his chest. The memory of his father’s face surfaced unbidden, that day in the neurologist’s office when they’d finally received the correct diagnosis after months of being told it was just anxiety or depression. The devastation in his eyes when he realized how much time they’d lost to uncertainty.
“Never rush to an incomplete conclusion,” his father had told him later. “But never hide from the truth either.”
Which was he doing now with Priya’s results? Protecting her from uncertainty, or himself from her reaction?
“Let’s continue with the orientation,” he said, gesturing Matthew toward the sample processing area. “Show me the freezer storage system you’ve implemented.”
For the next hour, they moved methodically through the lab procedures, how samples would be logged into the system, prepared in the spinning centrifuges that separated blood components, and stored in precise conditions to preserve their molecular information. Evan forced himself to concentrate, asking questions and verifying each step against his research protocol. The routine helped calm his racing thoughts.
“The minus 80 freezers have backup power and remote temperature monitoring,” Matthew explained, opening a massive stainless steel door that released a cloud of frigid air. “Alarms go to your phone and mine if there’s any deviation.”
“Good.” Evan examined the empty shelves, already labeled with study ID placeholders. “We’ll need to maintain precise temperature logs for regulatory compliance.”
“Already set up.” Matthew handed him a tablet showing a temperature tracking app. “Readings every fifteen minutes, backed up to the secure server.”
Evan nodded approvingly. Despite his youth and occasional overenthusiasm, Matthew was proving himself a competent research coordinator. The lab was well-organized, the protocols clearly documented. One less thing to worry about.
They moved to the computer workstation where the data management system was installed. Matthew logged in, demonstrating how patient records would be coded and tracked.
“Here’s where we’ll enter Dr. Raman’s baseline cognitive scores once we complete her testing,” he said, pulling up an empty data form. “The system automatically calculates deviations from normative values.”
Evan stared at the blank fields waiting to be populated with Priya’s data. Cognitive testing was scheduled for later in the week, after her MRI. But the positive oligoclonal bands already suggested an inflammatory process consistent with demyelination.
Should he tell her now? Or wait until he had the complete picture?
The lab door swung open, interrupting his thoughts. Walter Baker strode in, his tailored suit as out of place in the clinical setting as his confident smile.
“Dr. Davis, just the man I wanted to see.” Walter surveyed the lab with appreciative eyes. “Impressive setup. The board will be pleased to see their investment materializing.”
Evan straightened, instinctively placing himself between Walter and the computer screen displaying Priya’s empty data form. “Mr. Baker. I wasn’t aware we had a meeting scheduled.”
“Impromptu visit.” Walter clasped his hands behind his back. “The oversight committee is conducting a preliminary audit next week. Wanted to make sure everything’s on track.”
“An audit?” Evan exchanged glances with Matthew. “The research program just launched.”
“Standard procedure when external funding exceeds a certain threshold.” Walter’s tone was casual, but his eyes were sharp. “Nothing to worry about if enrollment is progressing as planned.”
The implied pressure was clear. Walter was checking on his thirty-day enrollment requirement.
“We’re following the protocol timeline,” Evan said carefully. “Initial screenings are underway.”
“Excellent.” Walter nodded. “And Dr. Raman? I understand she’s begun the evaluation process.”
The question sent a ripple of unease down Evan’s spine. Walter’s specific interest in Priya continued to strike him as inappropriate.
“Patient enrollment status is confidential,” Evan replied. “But yes, preliminary testing has begun for several candidates.”
Walter smiled, the expression not quite reaching his eyes. “The board is particularly interested in demonstrating how our own staff benefit from cutting-edge research. It makes for compelling fundraising narratives at events like the gala.”
The implication hung in the air, Priya’s potential diagnosis as a marketing tool. Evan felt a surge of protective indignation that surprised him with its intensity.
“Research participants aren’t fundraising props,” he said, his voice cooler than before. “Their medical information remains private unless they explicitly consent to sharing their stories.”
The vehemence of his response caught him off guard. He typically maintained professional distance, clinical detachment. But something about Walter’s casual commodification of Priya’s condition struck a nerve, one connected directly to his father’s experience as a “case” rather than a person.
Walter held up his hands in a placating gesture. “Of course, of course. Patient confidentiality is paramount. I’m merely suggesting that success stories, with appropriate consent, help secure ongoing funding.”
Matthew shifted uncomfortably beside the freezer, clearly sensing the tension.
“I should check on those reagent orders,” he murmured, making a tactical retreat to the supply room.
Once they were alone, Walter’s demeanor subtly changed, his smile fading into something more calculated.
“The thirty-day enrollment window is a non-negotiable contract term,” he said quietly, his voice dropping to ensure their privacy despite the empty lab. “If we don’t meet it, the first-year funding remains in escrow. The research wing remains half-built. Your groundbreaking work…” He gestured to the sophisticated equipment around them. “All of this, gone.”
The threat was elegant in its simplicity. Everything Evan had worked for, the promise he’d made at his father’s bedside, balanced against rushing a process that demanded precision.
“I’m aware of the terms,” Evan replied, his voice steadier than he felt. “But I won’t compromise scientific integrity or patient care to meet an arbitrary deadline. Not even for this study.”
“Noble sentiments.” Walter nodded. “But practically speaking, you need at least two borderline cases enrolled within the next twenty-seven days. Dr. Raman’s preliminary results suggest she qualifies. The question is whether you’ll act on that information efficiently.”
Evan stiffened. “How do you know about her preliminary results?”
“Board oversight includes access to aggregate research data.” Walter’s smile returned. “Not individual records, of course. But enrollment status updates. Dr. Wolfe mentioned expediting certain tests.”
The explanation was plausible but unsatisfying. Evan made a mental note to review the data access protocols with Matthew.
“I’ll handle Dr. Raman’s case according to established clinical and ethical guidelines,” he said firmly. “Not administrative timelines.”
“Of course.” Walter checked his watch. “I should let you get back to work. The audit team will be in touch to schedule their visit.”
He moved toward the door, then paused. “One more thing, Dr. Davis. Peninsula General has expressed interest in hosting your research if Cascade Bay’s infrastructure proves inadequate. Just something to keep in mind.”
The veiled threat lingered after Walter departed. Peninsula General was the larger hospital across the bay, part of a corporate healthcare system. Where Cascade Bay was independent and community-focused, Peninsula represented the growing trend of hospital consolidation, bigger systems absorbing smaller ones, often prioritizing efficiency over personalized care. The implication was clear, if Evan’s research failed here, it would be relocated, and Cascade Bay would lose both prestige and funding.
Matthew emerged cautiously from the supply room. “Is he gone?”
“Yes.” Evan ran a hand through his hair, frustration tightening his shoulders. “How often does he drop in like that?”
“More often lately.” Matthew returned to the computer station. “Ever since the merger talks started up again.”
“Merger talks?”
“Peninsula Healthcare has been trying to acquire us for years.” Matthew lowered his voice despite the empty lab. “The board’s split on whether to stay independent. Your research grant is kind of a big deal, proof we can attract cutting-edge medicine without corporate backing.”
“And Walter’s position?” Evan asked, recalling the Peninsula Healthcare cufflinks he’d noticed during their first meeting.
Matthew hesitated. “Officially neutral. Unofficially… let’s just say his consulting firm has several contracts with Peninsula’s parent company.”
Another layer of pressure. Evan’s research wasn’t just scientifically important; it was politically significant for the hospital’s future.
“Let’s get back to work,” he said, pushing Walter’s visit aside. “Show me the cognitive testing setup.”
They spent the next hour reviewing the cognitive testing setup, computerized tests that measured how quickly Priya could respond to stimuli, how effectively she could remember sequences, how precisely she could control small movements. Each test would reveal different aspects of how her brain was functioning.
But the CSF report continued to weigh on Evan’s mind. Positive oligoclonal bands were significant. She deserved to know about them. Professional ethics demanded transparency with patients about their test results.
Yet uncertainty remained. The bands alone weren’t diagnostic. Without MRI images showing the characteristic spots of damage to the protective coating around nerve fibers, the finding was suggestive but inconclusive. Telling her now might cause unnecessary anxiety if, by some small chance, the final diagnosis proved different.
His father’s face flashed in his memory, the confusion and fear when doctors had reversed their initial diagnosis, the precious months lost to incorrect treatment. The mistake that might have cost him years of life.
No. Better to wait for complete data. Better to be certain before disrupting Priya’s life with a diagnosis that would forever change her identity as a physician.
“I need to check on the monitoring apartment,” Evan said abruptly. “Is it ready for tonight?”
Matthew looked up from the cognitive testing computer. “Tonight? I thought Dr. Raman’s overnight monitoring was scheduled for next week.”
“Change of plans.” Evan gathered his tablet and the folder containing Priya’s partial records. “Her MRI is scheduled for Friday night, during the gala. I want baseline cognitive and motor function data before then.”
“I’ll call maintenance to make sure everything’s set up,” Matthew said, reaching for the phone. “The sensors arrived yesterday, but I haven’t had a chance to test them.”
“I’ll handle it.” Evan headed for the door. “Send me the access codes for the apartment.”
As he walked through the construction zone separating the lab from the residential wing, the sounds shifted from the clinical beeping of lab equipment to the industrial rhythm of drills and hammers. The physical transition mirrored his mental one, moving from objective researcher to something more complicated.
The decision crystallized with each step. Accelerating the monitoring schedule wasn’t just about gathering data points. It was buying time. Time to be certain. Time to prepare Priya for what the evidence suggested. Time to find the right words for a diagnosis that would redefine her identity.
The monitoring apartment occupied the far end of the research wing, designed to provide a homelike environment while capturing detailed neurological and physiological data. Unlike the clinical spaces, it had been fully completed, a priority for the study protocol.
Evan entered the access code Matthew texted him and pushed open the door. The space was modern but sterile, like an upscale hotel room that hadn’t yet been lived in. A small kitchen opened to a living area with comfortable furniture. Beyond that, a bedroom and bathroom. Recessed lighting, neutral colors, discreet cameras in the corners.
He moved to the control panel near the entrance, activating the monitoring systems. Screens illuminated around the apartment, displaying vital sign templates and movement tracking grids. In the bedroom, a sleep monitoring system waited beside a neatly made queen bed.
Evan opened a cabinet containing the wearable sensors, small adhesive patches no bigger than a bandage that would track everything from heartbeats to tiny muscle tremors. The technology was sophisticated but designed to be forgotten once placed on the skin. He removed one, turning it over in his hand. The technology was non-invasive but intimate. The patches would be placed on her chest, her wrist, her temple.
He swallowed, suddenly aware of the personal nature of what he was proposing. Twenty-four hours of continuous monitoring meant Priya would sleep here, shower here, eat here, all while he observed her neurological function from the adjacent control room.
Professional boundaries would be essential. Clinical detachment.
Yet as he arranged the sensors on the bedside table, Evan found himself thinking not of data points but of Priya herself, her direct gaze during their consultation, the subtle defiance in her posture, the moment her hand had trembled during the coordination test.
He remembered the specimen tube from her lumbar puncture, her name written in surprisingly elegant handwriting on the label. The way she’d winced slightly during the procedure but refused the extra lidocaine he’d offered.
These weren’t clinical observations. They were personal impressions, the kind he usually filtered out of his medical assessments.
Dangerous territory.
Evan’s phone vibrated in his pocket. He pulled it out, expecting Matthew with an update on the reagent delivery.
Instead, he found a missed call notification from his mother. Again. The third this week.
His thumb hovered over the callback button. Their last conversation had ended in tense silence after she’d asked, as she always did eventually, whether his research could have saved his father if it had existed ten years earlier. The question had no answer that brought peace to either of them.
Not today. Not with Priya’s results weighing on his mind, with the parallels between her early symptoms and his father’s becoming increasingly difficult to ignore.
He slipped the phone back into his pocket, next to the folded CSF report. The positive oligoclonal bands. The evidence he was choosing to withhold, at least temporarily.
Evan moved to the window, where late afternoon sunlight filtered through coastal fog. The apartment felt isolated, suspended between the hospital and the outside world. A liminal space where normal rules blurred.
The monitoring equipment hummed to life around him, ready to capture data, to quantify neurological function, to help confirm or rule out a diagnosis that would change Priya’s life forever.
He pulled the CSF report from his pocket, unfolding it carefully. The positive oligoclonal bands. Clinical evidence of inflammation consistent with demyelination. Evidence that pointed toward MS.
Evidence he was choosing to withhold.
Was he truly protecting Priya from uncertainty, as he’d told himself? Or protecting himself from the moment when he would have to watch her face transform with the realization, the moment when doctor became patient, colleague became subject?
The weight of the decision pressed against his chest. His father’s voice echoed in his memory: “The waiting was worse than knowing.” Yet here he was, imposing that same limbo on Priya.
His phone vibrated again. A text message this time: Still on for 1900 check-in?
Priya. Direct and to the point, asserting control over a situation where she was increasingly vulnerable.
Evan stared at the message. He should tell her now. Call her, explain the findings, prepare her for what the additional testing might confirm.
Instead, his thumbs typed: Yes. Apartment 4B in the research wing. Bring overnight essentials.
He sent the message, then stood motionless in the silent apartment, second-guessing his decision even as he committed to it. The monitoring would proceed. The data would accumulate. The diagnosis would clarify. And he would keep the preliminary results to himself until he had irrefutable proof.
The apartment’s motion sensors detected his stillness and dimmed the lights slightly, creating pools of shadow in the corners. In two hours, Priya would walk through that door, trusting him with her symptoms, her data, potentially her diagnosis.
And the evidence that might explain her trembling hand remained folded in his pocket, a secret he’d chosen to keep.
The decision felt irrevocable now, a small betrayal in service of certainty. A professional judgment that somehow, inexplicably, felt personal in ways Evan wasn’t prepared to examine.
He checked his watch again. One hour and fifty-six minutes until Priya arrived.
One hour and fifty-six minutes to convince himself he was doing the right thing.
You have been reading Diagnosis of the Heart...
The first rule of medicine is *do no harm*. Dr. Priya Raman sleeping with her brilliant, arrogant new neurologist probably counts.
Dr. Evan Davis is everything she shouldn’t want. Her colleague. Her doctor. The one man who holds her future in his capable hands.
He’s also devastatingly attractive, infuriatingly perceptive, and the only person who sees past the confident facade she shows the world.
When a medical crisis forces them into close quarters, professional boundaries become impossible to maintain. Every stolen glance burns. Every accidental touch ignites something they both know they should resist.
He wants to save her. She wants to save her career. Neither of them expected to fall this hard.
The hospital has rules about doctor-patient relationships. But some attractions are too powerful to deny.
